about
Dimethylfumarate specifically inhibits the mitogen and stress-activated kinases 1 and 2 (MSK1/2): possible role for its anti-psoriatic effect.IL-8 and p53 are inversely regulated through JNK, p38 and NF-kappaB p65 in HepG2 cells during an inflammatory response.Activator protein 1 DNA binding activity is decreased in lesional psoriatic skin compared with nonlesional psoriatic skin.Protein phosphatase 2Cδ/Wip1 regulates phospho-p90RSK2 activity in lesional psoriatic skin.Self-inflicted skin diseases. A retrospective analysis of 57 patients with dermatitis artefacta seen in a dermatology department.Genetic polymorphisms associated with psoriasis and development of psoriatic arthritis in patients with psoriasis.Safety, efficacy and drug survival of biologics and biosimilars for moderate-to-severe plaque psoriasis.Effectiveness and safety of secukinumab in 69 patients with moderate to severe plaque psoriasis: A retrospective multicenter study.Increased frequency of multiple sclerosis among patients with bullous pemphigoid: a population-based cohort study on comorbidities anchored around the diagnosis of bullous pemphigoid.Dimethylfumarate inhibits MIF-induced proliferation of keratinocytes by inhibiting MSK1 and RSK1 activation and by inducing nuclear p-c-Jun (S63) and p-p53 (S15) expression.Clonal Spread of Staphylococcus aureus with Reduced Susceptibility to Oxacillin in a Dermatological Hospital UnitDimethyl fumarate is an allosteric covalent inhibitor of the p90 ribosomal S6 kinases[A woman with hidrosadenitis suppurativa underwent multiple operations for abscesses]Dimethyl Fumarate Targets MSK1, RSK1, 2 and IKKα/β Kinases and Regulates NF-κB /p65 Activation in Psoriasis: A Demonstration of the Effect on Peripheral Blood Mononuclear Cells, Drawn from Two Patients with Severe Psoriasis Before and After Treatmen
P50
Q34627517-7CBDC0D9-AB54-4AAB-8F97-EA0533A9B8E1Q39964041-B5E9C35C-B15E-49E3-8D03-641916E6670EQ45065352-908252D5-0346-404C-BC82-B52B0C020EFBQ47106368-D785DF7D-3BA8-4C99-A2DB-CE56E038B6BFQ47299582-48943575-335D-461B-B2A2-2C816F720315Q47640799-FB697FCB-CF3F-4530-ADFA-5775F8DDE3E4Q47671991-0F5EE840-173C-4E17-AD8C-4A4CE219FAB4Q47987093-894FC5A9-1A8D-4379-94DC-BBA648624915Q50874000-ABF639FC-B4EE-4287-A532-E894783269ACQ54611162-0830E808-419F-42EA-8F43-9083529F4945Q57765049-66BBA226-E6F1-46D5-B7DE-6B2F30153C30Q57810919-227BAAC0-5772-4719-AC01-D5FE72B58E69Q58612550-3A2743FD-0960-4C6F-9E14-2C243C3FB016Q92066922-D14024D0-73C0-4935-8AB3-21613D14A33D
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mads Kirchheiner Rasmussen
@ast
Mads Kirchheiner Rasmussen
@en
Mads Kirchheiner Rasmussen
@es
Mads Kirchheiner Rasmussen
@nl
type
label
Mads Kirchheiner Rasmussen
@ast
Mads Kirchheiner Rasmussen
@en
Mads Kirchheiner Rasmussen
@es
Mads Kirchheiner Rasmussen
@nl
prefLabel
Mads Kirchheiner Rasmussen
@ast
Mads Kirchheiner Rasmussen
@en
Mads Kirchheiner Rasmussen
@es
Mads Kirchheiner Rasmussen
@nl
P106
P31
P496
0000-0001-8242-9377